CAS No. |
405229-61-0 |
|---|---|
中文名称 |
(2S,3R,4R,5R,6S)-2-(((2R,3S,4R,5R,6R)-4,5-二羟基-6-(((3S,4R,4aR,6aR,6bS,8S,8aS,12aS,14aR,14bR)-8-羟基-4,8a-双(羟甲基)-4,6a,6b,11,11,14b-六甲基-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-二十氢菲烯并(hexa?)cen-3-基)氧基))-2-((((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)甲基)四氢-2H-吡喃-3-基)氧基))-6-甲基四氢-2H-吡喃-3,4,5-三醇 |
英文名称 |
(2S,3R,4R,5R,6S)-2-(((2R,3S,4R,5R,6R)-4,5-dihydroxy-6-(((3S,4R,4aR,6aR,6bS,8S,8aS,12aS,14aR,14bR)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-2-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol |
别名 |
Nepasaikosaponin K;β-D-Glucopyranoside,(3β,4α,16β)-16,23,28-trihydroxyolean-12-en-3-ylO-6-deoxy-α-L-mannopyranosyl-(1→4)-O-[β-D-glucopyranosyl-(1→6)]-;Saikosaponin K |
标准英文名 |
(2S,3R,4R,5R,6S)-2-(((2R,3S,4R,5R,6R)-4,5-dihydroxy-6-(((3S,4R,4aR,6aR,6bS,8S,8aS,12aS,14aR,14bR)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-2-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol |
MDL No. |
MFCD35146187 |
分子式 |
C48H80O18 |
分子量 |
945.15 |
精确分子量 |
944.53 |
SMILES |
C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(CO)[C@@H](O)C[C@]45C)[C@]3(C)CO)O[C@@H]2CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O |
标准SMILES |
CC1(C)C[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@]2(CC1)CO |
用途 |
Nepasaikosaponin K (Saikosaponin K) is used as a reference standard and analytical control in laboratory research and pharmaceutical/chemical manufacturing processes. It exhibits a range of pharmacological activities, including antitumor (EAC), hepatoprotective (against CCl4-induced hepatotoxicity in rats), antiviral (influenza A2 virus in vitro, 69% inhibition at 50 μg/mL), antihyperlipidemic, anti-endotoxin, immunomodulatory, anti-platelet-activating factor, anti-allergic, and anti-cell adhesion effects. |
InChIKey |
BHFXAIXRWOFWOS-XRWUOUDGSA-N |
|
|
评论 |
|---|